CETP and metabolic syndrome: These results align with previous trials, such as the ACCELERATE study (Lincoff et al., 2017), and a trial done by Nicholls et al. (2011) which demonstrated that CETP inhibitors in combination with statins provide a comprehensive approach to managing dyslipidemia [35, 37].